MYELODYSPLASTIC SYNDROMES
Clinical trials for MYELODYSPLASTIC SYNDROMES explained in plain language.
Never miss a new study
Get alerted when new MYELODYSPLASTIC SYNDROMES trials appear
Sign up with your email to follow new studies for MYELODYSPLASTIC SYNDROMES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental stem cell shot aims to stop transplant rejection in blood cancer patients
Disease control TerminatedThis early-stage study tested whether giving patients a special type of stem cell (called interferon gamma-primed mesenchymal stromal cells) around the time of a bone marrow transplant could safely prevent graft-versus-host disease, a serious complication where donor cells attack…
Matched conditions: MYELODYSPLASTIC SYNDROMES
Phase: PHASE1 • Sponsor: Edwin Horwitz • Aim: Disease control
Last updated Apr 28, 2026 21:36 UTC
-
Early-Study of drug combos for rare blood cancer halted
Knowledge-focused TerminatedThis early-phase study aimed to find safe doses of certain drug combinations for adults with a mild form of myelodysplastic syndrome (MDS), a blood cancer. Researchers planned to enroll 33 participants to monitor side effects and treatment adjustments. However, the study was term…
Matched conditions: MYELODYSPLASTIC SYNDROMES
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated Apr 28, 2026 21:36 UTC